talimogene laherparepvec · Medicine question

Which immune-mediated events have been reported in patients treated with Imlygic (talimogene laherparepvec)?

Name: Which immune-mediated events have been reported in patients treated with Imlygic (talimogene laherparepvec)?
Published: 2026-11-08T02:02:31.165Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Immune-mediated events reported in clinical studies in patients treated with Imlygic (talimogene laherparepvec) include glomerulonephritis, vasculitis, pneumonitis, worsening psoriasis and vitiligo.

Sources for this answer

ImlygicAmgen Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 14Document updated 19 May 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about talimogene laherparepvec